Other Income & Expense
Other Charges
Year-over-year, this metric declined by 104.0%, from $7.32B to -$294.00M. Over 4 years (FY 2021 to FY 2025), Other Charges shows an upward trend with a 95.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2007
Last reportedQ1 2026Apr 22, 2026
How to read this metric
An increase suggests unexpected non-operating costs or one-time financial hits, which can negatively impact net income.
Detailed definition
This metric captures non-operating financial expenses that do not fall under standard categories like interest or taxes....
Peer comparison
Often found in the non-operating section of the income statement; peers may label these as 'other expenses' or 'sundry charges'.
Metric ID:
hon_other_chargesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $488.00M | -$1.85B | -$46.00M | $102.00M | -$273.00M | -$226.00M | -$795.00M | -$6.94B | $384.00M | -$499.00M | $0.00 | -$2.40B | -$653.00M | -$1.80B | $0.00 | $7.32B | -$107.00M | $478.00M | $0.00 | -$294.00M |
| QoQ Change | — | -479.1% | +97.5% | +321.7% | -367.6% | +17.2% | -251.8% | -773.0% | +105.5% | -229.9% | +100.0% | — | +72.8% | -175.3% | +100.0% | — | -101.5% | +546.7% | -100.0% | — |
| YoY Change | — | — | — | — | -155.9% | +87.8% | <-999% | <-999% | +240.7% | -120.8% | +100.0% | +65.4% | -270.1% | -260.3% | — | +404.5% | +83.6% | +126.6% | — | -104.0% |
Range-$6.94B – $7.32B
CAGR-10.1%
Avg YoY Growth-595.3%
Median YoY Growth-19.3%
Current Streak2 quarters decline
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| MEDTECH | -$60.00M | $190.00M | $2.00M | $806.00M | $76.00M |
| Innovative Medicine | -$166.00M | $14.00M | -$368.00M | -$193.00M | -$12.00M |
| Total | $7.32B | -$107.00M | $478.00M | $0.00 | -$294.00M |
Other Charges at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's other charges?
- Johnson & Johnson (JNJ) reported other charges of -$294.00M in Q1 2026.
- How has Johnson & Johnson's other charges changed year-over-year?
- Johnson & Johnson's other charges decreased by 104.0% year-over-year, from $7.32B to -$294.00M.
- What is the long-term trend for Johnson & Johnson's other charges?
- Over 4 years (2021 to 2025), Johnson & Johnson's other charges has grown at a 95.6% compound annual growth rate (CAGR), from -$526.00M to $7.69B.
- What does other charges mean?
- Miscellaneous non-operating financial expenses not classified elsewhere.